Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds having activity of suppressing activation of TGF-β receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis C virus

Compounds having activity of suppressing activation of TGF-β receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis C virus

US Patent 8951521 · Granted Feb 10, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human NTCP-binding antibody capable of inhibiting infection of hepatitis B virus2025
Antibody against human TGF-β LAP degradate, and use thereof2022
Antibody against human TGF-β LAP degradate, and use thereof2022
Pyridinone compound and use thereof2019
TGF-β signal transduction inhibitor2014
TGF-β signal transduction inhibitor2014
Antibodies that recognize cutting edge within the TGF-β activation controlling r2012
Methods of use of antibodies which recognize a protease cleavage site of an LAP 2010